CHRISTOPHER CASE: Open Payments
NPI 1871552794 · JEFFERSON CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,590 in 42 payments from 10 companies in 2025. Trend: 2023 $8,655 · 2024 $10,609 · 2025 $8,590
Speaker / faculty: $5,255Consulting: $2,790Food & beverage: $514Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $8,354 |
| Xeris Pharmaceuticals, Inc. | 3 | $53 |
| Corcept Therapeutics | 2 | $37 |
| PFIZER INC. | 1 | $29 |
| Medtronic, Inc. | 1 | $26 |
| Radius Health, Inc. | 1 | $19 |
| Abbott Laboratories | 1 | $19 |
| TOLMAR, INC. | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: Ozempic, Wegovy, RECORLEV, Rybelsus, Korlym, PREVNAR 20, KYPHON EXPRESS II KYPHOPAK TRAY, Tymlos.
Industry payments across MO — which companies pay providers there.
